Gen Trust, LLC Edwards Lifesciences Corp Transaction History

Gen Trust, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$106.37 - $130.68 $54,035 - $66,385	-508 Reduced 17.81%	2,345 $254,000
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $52,278 - $62,357	508 Added 21.66%	2,853 $323,000
Q2 2021 Aug 10, 2021	BUY	$83.84 - $104.76 $196,604 - $245,662	2,345 New	2,345 $243,000
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $184,504 - $212,621	-2,345 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $21,507 - $27,369	-300 Reduced 11.34%	2,345 $214,000
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $177,717 - $231,278	2,645 New	2,645 $211,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Gen Trust, LLC, based on Form 13F filings with the SEC.

Stay updated on Gen Trust, LLC with notifications on news.